Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer

OBJECTIVE: To assess the cost-effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer. METHODS: An analytical decision model was developed to determine the cost-effectiveness of chemohormonal therapy versus androgen deprivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar, Pedro Nazareth, Barreto, Carmélia Maria Noia, Gutierres, Bárbara de Souza, Tadokoro, Hakaru, Lopes, Gilberto de Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2017
Materias:
Health Economics and Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823051/
https://www.ncbi.nlm.nih.gov/pubmed/29091159
http://dx.doi.org/10.1590/S1679-45082017GS4017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823051/
https://www.ncbi.nlm.nih.gov/pubmed/29091159
http://dx.doi.org/10.1590/S1679-45082017GS4017

Ejemplares similares